GSK plc
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Large accelerated filer
State of Incorporation
United Kingdom
Country
United Kingdom
Business Address
79 NEW OXFORD STREET, LONDON, , WC1A 1DG
Mailing Address
79 NEW OXFORD STREET, LONDON, , WC1A 1DG
Phone
44 20 8047 5000
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | April 10, 2026 | View on SEC |
| 6-K Foreign company current report | April 10, 2026 | View on SEC |
| 6-K Foreign company current report | April 9, 2026 | View on SEC |
| 6-K Foreign company current report | April 9, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 8, 2026 | View on SEC |
| 6-K Foreign company current report | April 7, 2026 | View on SEC |
| 6-K Foreign company current report | April 2, 2026 | View on SEC |
| 6-K Foreign company current report | April 1, 2026 | View on SEC |
| 6-K Foreign company current report | April 1, 2026 | View on SEC |
Annual Reports
20-F
March 6, 2026
- GSK achieved strong operational and financial performance in 2023, driven by innovative Specialty Medicines and Vaccines.
- The company maintains market leadership in vaccines (e.g., shingles, RSV) and HIV, with a growing specialty medicines portfolio.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.